157 related articles for article (PubMed ID: 23900414)
1. Blockade of the PDGFR family together with SRC leads to diminished proliferation of colorectal cancer cells.
Kaulfuß S; Seemann H; Kampe R; Meyer J; Dressel R; König B; Scharf JG; Burfeind P
Oncotarget; 2013 Jul; 4(7):1037-49. PubMed ID: 23900414
[TBL] [Abstract][Full Text] [Related]
2. The role of lysyl oxidase in SRC-dependent proliferation and metastasis of colorectal cancer.
Baker AM; Cox TR; Bird D; Lang G; Murray GI; Sun XF; Southall SM; Wilson JR; Erler JT
J Natl Cancer Inst; 2011 Mar; 103(5):407-24. PubMed ID: 21282564
[TBL] [Abstract][Full Text] [Related]
3. Ki11502, a novel multitargeted receptor tyrosine kinase inhibitor, induces growth arrest and apoptosis of human leukemia cells in vitro and in vivo.
Nishioka C; Ikezoe T; Yang J; Miwa A; Tasaka T; Kuwayama Y; Togitani K; Koeffler HP; Yokoyama A
Blood; 2008 May; 111(10):5086-92. PubMed ID: 18309036
[TBL] [Abstract][Full Text] [Related]
4. Platelet‑derived growth factor receptor‑β gene expression relates to recurrence in colorectal cancer.
Fujino S; Miyoshi N; Ohue M; Takahashi Y; Yasui M; Hata T; Matsuda C; Mizushima T; Doki Y; Mori M
Oncol Rep; 2018 May; 39(5):2178-2184. PubMed ID: 29498405
[TBL] [Abstract][Full Text] [Related]
5. Platelet-derived growth factor (PDGF) cross-signaling via non-corresponding receptors indicates bypassed signaling in colorectal cancer.
Moench R; Gasser M; Nawalaniec K; Grimmig T; Ajay AK; de Souza LCR; Cao M; Luo Y; Hoegger P; Ribas CM; Ribas-Filho JM; Malafaia O; Lissner R; Hsiao LL; Waaga-Gasser AM
Oncotarget; 2022 Oct; 13():1140-1152. PubMed ID: 36264073
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of PDGFR by CP-673451 induces apoptosis and increases cisplatin cytotoxicity in NSCLC cells via inhibiting the Nrf2-mediated defense mechanism.
Yang Y; Deng Y; Chen X; Zhang J; Chen Y; Li H; Wu Q; Yang Z; Zhang L; Liu B
Toxicol Lett; 2018 Oct; 295():88-98. PubMed ID: 29857117
[TBL] [Abstract][Full Text] [Related]
7. FAM83D knockdown regulates proliferation, migration and invasion of colorectal cancer through inhibiting FBXW7/Notch-1 signalling pathway.
Mu Y; Zou H; Chen B; Fan Y; Luo S
Biomed Pharmacother; 2017 Jun; 90():548-554. PubMed ID: 28407575
[TBL] [Abstract][Full Text] [Related]
8. Dasatinib sensitizes KRAS mutant colorectal tumors to cetuximab.
Dunn EF; Iida M; Myers RA; Campbell DA; Hintz KA; Armstrong EA; Li C; Wheeler DL
Oncogene; 2011 Feb; 30(5):561-74. PubMed ID: 20956938
[TBL] [Abstract][Full Text] [Related]
9. Selective inhibition of PDGFR by imatinib elicits the sustained activation of ERK and downstream receptor signaling in malignant glioma cells.
Dong Y; Jia L; Wang X; Tan X; Xu J; Deng Z; Jiang T; Rainov NG; Li B; Ren H
Int J Oncol; 2011 Feb; 38(2):555-69. PubMed ID: 21152856
[TBL] [Abstract][Full Text] [Related]
10. PKG II inhibits PDGF-BB triggered biological activities by phosphorylating PDGFRβ in gastric cancer cells.
Wang Y; Appiah-Kubi K; Lan T; Wu M; Pang J; Qian H; Tao Y; Jiang L; Wu Y; Chen Y
Cell Biol Int; 2018 Sep; 42(10):1358-1369. PubMed ID: 29935031
[TBL] [Abstract][Full Text] [Related]
11. Characterisation of Ki11502 as a potent inhibitor of PDGF beta receptor-mediated proteoglycan synthesis in vascular smooth muscle cells.
Getachew R; Ballinger ML; Burch ML; Little PJ; Osman N
Eur J Pharmacol; 2010 Jan; 626(2-3):186-92. PubMed ID: 19818754
[TBL] [Abstract][Full Text] [Related]
12. A dual inhibitor of platelet-derived growth factor beta-receptor and Src kinase activity potently interferes with motogenic and mitogenic responses to PDGF in vascular smooth muscle cells. A novel candidate for prevention of vascular remodeling.
Waltenberger J; Uecker A; Kroll J; Frank H; Mayr U; Bjorge JD; Fujita D; Gazit A; Hombach V; Levitzki A; Böhmer FD
Circ Res; 1999 Jul; 85(1):12-22. PubMed ID: 10400906
[TBL] [Abstract][Full Text] [Related]
13. Validation of PDGFRbeta and c-Src tyrosine kinases as tumor/vessel targets in patients with multiple myeloma: preclinical efficacy of the novel, orally available inhibitor dasatinib.
Coluccia AM; Cirulli T; Neri P; Mangieri D; Colanardi MC; Gnoni A; Di Renzo N; Dammacco F; Tassone P; Ribatti D; Gambacorti-Passerini C; Vacca A
Blood; 2008 Aug; 112(4):1346-56. PubMed ID: 18524994
[TBL] [Abstract][Full Text] [Related]
14. RON Receptor Tyrosine Kinase Regulates Epithelial Mesenchymal Transition and the Expression of Pro-Fibrotic Markers via Src/Smad Signaling in HK-2 and NRK49F Cells.
Park JS; Choi HI; Kim DH; Kim CS; Bae EH; Ma SK; Kim SW
Int J Mol Sci; 2019 Nov; 20(21):. PubMed ID: 31690042
[TBL] [Abstract][Full Text] [Related]
15. [Abnormal expression of APRIL in colorectal cancer cells promotes tumor growth and metastasis].
Wang GH; Lu MH; Wang JC; Wang F; Ding WF; Wang YG; Ju SQ; Wang HM
Zhonghua Zhong Liu Za Zhi; 2013 Apr; 35(4):249-55. PubMed ID: 23985251
[TBL] [Abstract][Full Text] [Related]
16. PDGF-D/PDGFRβ promotes tongue squamous carcinoma cell (TSCC) progression via activating p38/AKT/ERK/EMT signal pathway.
Zhang H; Sun JD; Yan LJ; Zhao XP
Biochem Biophys Res Commun; 2016 Sep; 478(2):845-51. PubMed ID: 27507215
[TBL] [Abstract][Full Text] [Related]
17. The platelet-derived growth factor receptor-beta phosphorylates and activates G protein-coupled receptor kinase-2. A mechanism for feedback inhibition.
Wu JH; Goswami R; Kim LK; Miller WE; Peppel K; Freedman NJ
J Biol Chem; 2005 Sep; 280(35):31027-35. PubMed ID: 15994317
[TBL] [Abstract][Full Text] [Related]
18. Novel β-phenylacrylic acid derivatives exert anti-cancer activity by inducing Src-mediated apoptosis in wild-type KRAS colon cancer.
Kim SJ; Noh TH; Son S; Kim DH; Kim W; Lee Y; Choo J; Heo G; Kim MJ; Chung HY; Jung Y; Jung JH; Moon HR; Im E
Cell Death Dis; 2018 Aug; 9(9):877. PubMed ID: 30158525
[TBL] [Abstract][Full Text] [Related]
19. A role for the non-receptor tyrosine kinase ACK1 in TNF-alpha-mediated apoptosis and proliferation in human intestinal epithelial caco-2 cells.
Zhao X; Lv C; Chen S; Zhi F
Cell Biol Int; 2018 Sep; 42(9):1097-1105. PubMed ID: 28921811
[TBL] [Abstract][Full Text] [Related]
20. Imatinib disrupts lymphoma angiogenesis by targeting vascular pericytes.
Ruan J; Luo M; Wang C; Fan L; Yang SN; Cardenas M; Geng H; Leonard JP; Melnick A; Cerchietti L; Hajjar KA
Blood; 2013 Jun; 121(26):5192-202. PubMed ID: 23632889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]